Navigation Links
DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
Date:11/16/2009

EDEN PRAIRIE, Minn., Nov. 16 /PRNewswire/ -- Announced on November 06, 2009 by Mr. Mark Davis, the President and CEO of DAVISCO Foods International Inc., and the Board of MEGGLE Group of Wasserburg, Germany, represented by Drs Sil H. van der Ploeg, CEO, and Mr. Christian Sedlatschek, CFO, the companies are entering a long-term partnership for the production of pharmaceutical lactose in the United States.

DAVISCO Foods is an international cheese and food ingredient company, founded in 1943, headquartered in Le Sueur, MN., a privately-held, family-owned business. DAVISCO is a company committed to technical advancement, customer service, and the production of superior quality products.

The holding group MEGGLE AG, whose headquarters are in Wasserburg, Germany was founded in 1887 and bundles the activities of the different companies within the milk and whey-processing business group. This structure embodies flexibility and decisiveness on the one hand and the traditional character of the dairy with its long history of milk-processing on the other. The Business Group Excipients & Technology is considered the leading producer of pharmaceutical lactose and excels in particular in offering High - Tech, innovative excipients to the pharmaceutical industry worldwide.

DAVISCO will expand their existing lactose production at the Le Sueur facility to accommodate additional production lines for the production of pharmaceutical lactose utilizing state-of-the-art processing technology.

MEGGLE will provide the technical marketing, sales and distribution for the pharmaceutical lactose products.

"DAVISCO Foods Intl. Inc. is excited and honored to engage in a joint venture with the MEGGLE Company to produce pharmaceutical lactose products. We have had a close and rewarding relationship for years with MEGGLE and have respected and admired their many achievements. The joint venture will produce the same high quality products and provide the same service that MEGGLE has historically produced and provided." Mr. Mark Davis, President DAVISCO Food International Inc.

"MEGGLE highly appreciates the partnership with DAVISCO. This is an important step in our strategy to expand our capacities and at the same time to offer our customers worldwide the security of a second production site." Drs Sil H. van der Ploeg, CEO of MEGGLE

www.DAVISCOFoods.com

www.MEGGLE.com

SOURCE DAVISCO Foods International, Inc.


'/>"/>
SOURCE DAVISCO Foods International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Soyfoods Do Not Impact Sperm Count
2. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
3. Natural Alternatives International, Inc. Announces Filing of Patent Infringement Lawsuit
4. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
5. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
6. Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
9. WellTek/MedX Group Completes Major Reorganization
10. Hill-Rom and Encompass Group Form Joint Venture
11. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):